AxoGen (AXGN) Competitors $15.58 -0.07 (-0.45%) Closing price 04/16/2025 04:00 PM EasternExtended Trading$15.75 +0.17 (+1.09%) As of 08:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AXGN vs. PRCT, NVST, TMDX, LIVN, ENOV, NVCR, LMAT, CNMD, WRBY, and CDREShould you be buying AxoGen stock or one of its competitors? The main competitors of AxoGen include PROCEPT BioRobotics (PRCT), Envista (NVST), TransMedics Group (TMDX), LivaNova (LIVN), Enovis (ENOV), NovoCure (NVCR), LeMaitre Vascular (LMAT), CONMED (CNMD), Warby Parker (WRBY), and Cadre (CDRE). These companies are all part of the "medical equipment" industry. AxoGen vs. PROCEPT BioRobotics Envista TransMedics Group LivaNova Enovis NovoCure LeMaitre Vascular CONMED Warby Parker Cadre PROCEPT BioRobotics (NASDAQ:PRCT) and AxoGen (NASDAQ:AXGN) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, community ranking, institutional ownership, profitability, earnings, media sentiment, analyst recommendations and risk. Which has higher earnings & valuation, PRCT or AXGN? AxoGen has lower revenue, but higher earnings than PROCEPT BioRobotics. AxoGen is trading at a lower price-to-earnings ratio than PROCEPT BioRobotics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPROCEPT BioRobotics$224.50M12.90-$105.90M-$1.76-30.01AxoGen$187.34M3.69-$21.72M-$0.22-70.82 Does the media prefer PRCT or AXGN? In the previous week, PROCEPT BioRobotics had 6 more articles in the media than AxoGen. MarketBeat recorded 14 mentions for PROCEPT BioRobotics and 8 mentions for AxoGen. AxoGen's average media sentiment score of 1.15 beat PROCEPT BioRobotics' score of 1.03 indicating that AxoGen is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PROCEPT BioRobotics 7 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive AxoGen 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in PRCT or AXGN? AxoGen received 416 more outperform votes than PROCEPT BioRobotics when rated by MarketBeat users. Likewise, 72.89% of users gave AxoGen an outperform vote while only 69.49% of users gave PROCEPT BioRobotics an outperform vote. CompanyUnderperformOutperformPROCEPT BioRoboticsOutperform Votes4169.49% Underperform Votes1830.51% AxoGenOutperform Votes45772.89% Underperform Votes17027.11% Do institutionals and insiders hold more shares of PRCT or AXGN? 89.5% of PROCEPT BioRobotics shares are owned by institutional investors. Comparatively, 80.3% of AxoGen shares are owned by institutional investors. 17.4% of PROCEPT BioRobotics shares are owned by company insiders. Comparatively, 7.0% of AxoGen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is PRCT or AXGN more profitable? AxoGen has a net margin of -7.91% compared to PROCEPT BioRobotics' net margin of -50.07%. AxoGen's return on equity of -14.91% beat PROCEPT BioRobotics' return on equity.Company Net Margins Return on Equity Return on Assets PROCEPT BioRobotics-50.07% -38.57% -26.06% AxoGen -7.91%-14.91%-7.49% Do analysts recommend PRCT or AXGN? PROCEPT BioRobotics currently has a consensus target price of $91.43, suggesting a potential upside of 73.13%. AxoGen has a consensus target price of $22.60, suggesting a potential upside of 45.06%. Given PROCEPT BioRobotics' higher possible upside, equities analysts clearly believe PROCEPT BioRobotics is more favorable than AxoGen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PROCEPT BioRobotics 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86AxoGen 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, PRCT or AXGN? PROCEPT BioRobotics has a beta of 1.09, indicating that its share price is 9% more volatile than the S&P 500. Comparatively, AxoGen has a beta of 1, indicating that its share price has a similar volatility profile to the S&P 500. SummaryPROCEPT BioRobotics and AxoGen tied by winning 9 of the 18 factors compared between the two stocks. Remove Ads Get AxoGen News Delivered to You Automatically Sign up to receive the latest news and ratings for AXGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AXGN vs. The Competition Export to ExcelMetricAxoGenElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$690.88M$3.10B$5.29B$7.35BDividend YieldN/A1.78%5.11%4.32%P/E Ratio-48.6914.6721.6917.68Price / Sales3.6943.53373.4492.91Price / CashN/A44.0938.1534.64Price / Book7.023.286.353.94Net Income-$21.72M$94.03M$3.20B$247.45M7 Day Performance-1.39%0.36%3.93%3.17%1 Month Performance-14.77%-11.20%-10.36%-8.53%1 Year Performance124.50%-21.63%10.24%0.31% AxoGen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AXGNAxoGen2.9401 of 5 stars$15.58-0.4%$22.60+45.1%+122.6%$690.88M$187.34M-48.69450Short Interest ↑Positive NewsPRCTPROCEPT BioRobotics2.4067 of 5 stars$50.83-0.8%$94.29+85.5%+1.6%$2.79B$224.50M-26.07430Positive NewsGap DownHigh Trading VolumeNVSTEnvista4.3704 of 5 stars$15.27-1.4%$20.18+32.2%-24.0%$2.63B$2.51B-2.3512,700Analyst ForecastAnalyst RevisionPositive NewsGap DownTMDXTransMedics Group2.7671 of 5 stars$69.15+2.2%$122.70+77.4%-8.5%$2.33B$441.54M73.56210LIVNLivaNova3.5618 of 5 stars$35.40-1.5%$61.17+72.8%-34.1%$1.92B$1.25B84.292,900Positive NewsHigh Trading VolumeENOVEnovis2.1962 of 5 stars$32.41-0.4%$58.50+80.5%-44.9%$1.85B$2.11B-14.806,800NVCRNovoCure3.3348 of 5 stars$16.61+0.7%$35.80+115.5%+27.0%$1.83B$605.22M-11.861,320Upcoming EarningsAnalyst ForecastNews CoverageGap DownLMATLeMaitre Vascular3.1077 of 5 stars$79.39-0.5%$95.25+20.0%+32.0%$1.79B$219.86M43.38490Positive NewsHigh Trading VolumeCNMDCONMED4.6388 of 5 stars$55.34-1.6%$77.20+39.5%-37.9%$1.71B$1.31B13.054,100News CoverageWRBYWarby Parker3.3207 of 5 stars$15.43-2.2%$23.43+51.8%+12.8%$1.60B$771.32M-57.153,491Analyst ForecastPositive NewsGap DownCDRECadre3.4538 of 5 stars$28.30+0.5%$37.00+30.7%-8.5%$1.15B$567.56M34.102,240 Remove Ads Related Companies and Tools Related Companies PRCT Alternatives NVST Alternatives TMDX Alternatives LIVN Alternatives ENOV Alternatives NVCR Alternatives LMAT Alternatives CNMD Alternatives WRBY Alternatives CDRE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AXGN) was last updated on 4/17/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AxoGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AxoGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
